Our corporate and commercial team is known for its energy, business insight and legal expertise – nationally and internationally. We give clients commercially focused legal advice on all aspects of corporate law and regulation affecting public and private companies, private equity firms and management teams.
Our expertise spans:
- commercial contracts
- compliance, including regulatory, corporate governance and directors’ duties
- intellectual property
- mergers and acquisitions, joint ventures, shareholders arrangements, MBOs and MBIs
- privacy, and
- industry focus, including sports and entertainment, and technology and digital economy.
Our clients range from large multinational corporates through to ASX-listed companies and innovative start-ups. They include Carlton and United Breweries, Arena REIT, BMW Financial Services and Australian Unity. We are also trusted advisors to various corporate advisers and accounting firms.
‘The “brilliant, efficient, client-focused” team at Hall & Wilcox is “very thorough, knowledgeable”, and has “great strength in depth”. It counts IT, sports, financial services and real estate as sector strengths.’
The Legal 500 Asia Pacific 2018
Corporate and Commercial| 29 Jul 2020
The impact of COVID-19 on corporate transactions continues to be felt across numerous industries. In the second webinar of this series, held by Hall & Wilcox and FTI Consulting, we look at COVID-19 affected transaction terms.
COVID-19 Thinking| 29 Jul 2020
As the scale of the second wave of the COVID-19 pandemic in Victoria threatens to cast the nation into a relapse, the Federal Government’s announcements in the last week that it will extend critical government measures are welcome news.
Financial Services| 23 Jul 2020
In this edition of Financial Services in Focus, partners Harry (Cheski) New, Adrian Verdnik and Vince Battaglia provide commentary on the latest ASIC updates, discuss the ASX's extension of temporary emergency capital raising relief to 30 November, plus much more.
Corporate and Commercial| 16 Jul 2020
On-demand webinar | COVID-19 and expedited approval of therapeutic goods webinar – a global perspective
This recent webinar delves into what the regulators (TGA, FDA and European Medicines Agency) are doing to facilitate the supply of therapeutic goods to market quickly due to COVID-19.